drugset / Trial / NCT00007917

Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors

NCT00007917

Phase 1 Completed 58 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of gemcitabine plus flavopiridol in treating patients who have advanced solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Timeline

Start
2001-01
Primary completion
2010-09
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule Intravenous
Subject alvocidib Small molecule Intravenous